Each AHSN issues challenges in response to defined NHS needs. They describe the needs of the NHS in a local or national context and are shown on the AHSN page. They set out the market opportunity for an innovator – you can also view all challenges across the AHSN network.
Find your nearest AHSN
£150,000 available for innovative healthcare projects as Health Innovation Manchester launches new round of Momentum Funding
Companies can apply for a share of £150,000 as Health Innovation Manchester’s Momentum Fund opens for innovations which can benefit Greater Manchester and Eastern Cheshire’s healthcare system.
Developing partnerships for NHSx AI Award applications
The Artificial Intelligence (AI) in Health and Care Award aims to benefit patients by combining the power of artificial intelligence with the expertise of the NHS to improve health and care outcomes. The Award is making £140 million available over four years to accelerate the testing and evaluation of technologies most likely to meet the aims set out in the NHS Long Term Plan. Each round of the Award supports technologies at different levels of maturity, targeting health and care improvements where they are needed most, by both patients and NHS staff. These competitions have been designed to support innovators and technologies across the spectrum of development - from concept through to initial NHS adoption and testing of the AI technology within clinical pathways
Support for Rapid Uptake Product - FeNO Testing - 2021/22
The Accelerated Access Collaborative at NHS England and Improvement has been working with the AHSN Network to roll out FeNO testing to help improve the diagnosis of asthma.
Improving detection and management of high cholesterol to prevent cardiovascular disease
Cholesterol-lowering treatment is an effective intervention for the primary and secondary prevention of cardiovascular conditions, such as stroke and myocardial infarction (commonly known as a heart attack). However, many people are unaware they have high cholesterol, or receive sub-optimal treatment for it.
Greater Manchester Research and Innovation Health Accelerator
New Greater Manchester health accelerator programme invites innovative companies to collaborate with NHS and research organisations
Learning Disability: A Call To Action
We have launched a ‘call to action’ to third sector, industry and academia partners to seek new and improved ways of tackling the challenges of supporting citizens in Kent, Surrey and Sussex who have a learning disability. The aim of the call is to determine how we could better support our region through delivering new approaches, or to find additional solutions for existing approaches.
Hospital Episode Statistics data service
Wessex AHSN has access to a platform that allows our staff to query and interrogate Hospital Episode Statistics (HES) data. HES data is a database containing details of all admissions, ED attendances and outpatient appointments at NHS hospitals in England. Access to this data allows us to quantify the existing scale and costs of specific patient pathways, which can be used by innovators as a lever for change to demonstrate the improvements they can bring to the NHS.
Prevention of ill health
Combatting preventable causes of disease is a key NHS priority. According to the King’s Fund, seven in ten adults do not follow the NHS-recommended guidelines on tobacco, alcohol, diet and physical activity, which contribute to such health conditions as cancer, cardiovascular disease, diabetes and poor mental health. NHS organisations need to collaborate with local authorities and other partners to provide the tools, support and education to help south Londoners tackle the causes of poor health, live healthier lifestyles and close the physical and mental health gap.
Improving interventions and reducing invasive investigations in cardiovascular disease
Despite being one of the most preventable and intervenable health conditions, cardiovascular disease (CVD) is responsible for one in four premature deaths in the UK and accounts for the largest gap in healthy life expectancy. It is identified as the single biggest condition where lives can be saved by the NHS over the next 10 years. As such, the NHS has an ambition to help prevent over 150,000 heart attacks, strokes and dementia cases over the next 10 years. What innovations could be deployed to help solve this significant, unmet health need?
Funding for ideas that address COVID-19
UK Research & Innovationare offering rapid response for short term research and innovation projects addressing and mitigating the health, social, economic and environmental impacts of the COVID-19 outbreak.
Cardiovascular disease prevention
UCLPartners is committed to progressing its Cardiovascular Disease (CVD) prevention programme to drive large scale prevention of heart attacks, strokes and other circulatory problems.